Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus

Nature Genetics

Volumn 12, Issue 3, 1996, Pages 309-311

  Phelan, Catherine M ^a,b   Rebbeck, Timothy R ^c   Weber, Barbara L ^c   Devilee, Peter ^d   Ruttledge, Martin H ^a   Lynch, Henry T ^e   Lenoir, Gilbert M ^f   Stratton, Michael R ^g   Easton, Douglas F ^h   Ponder, Bruce A J ^h   Cannon Albright, Lisa ⁱ   Larsson, Catharina ^b   Goldgar, David E ⁱ   Narod, Steven A ^a,j  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d LEIDEN UNIVERSITY   (Netherlands)

^e CREIGHTON UNIVERSITY   (United States)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^j WOMEN S COLLEGE HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 11P; FEMALE; GENE LOCUS; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL;

ADULT; ALLELES; BASE SEQUENCE; BRCA1 PROTEIN; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 17; DNA PRIMERS; FEMALE; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MINISATELLITE REPEATS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 13344268996     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0396-309     Document Type: Article

References (19)

1. Easton, D., Ford, D., Bishop, D. & Consortium, B C L Breast and Ovarian cancer incidence in BRCA1- mutation carriers Am. J Hum Genet. 56, 265-271 (1995).
2. Lidereau, R et al. High frequency of rare alleles of the human c-Ha-ras-1 protooncogene in breast cancer patients J. Natl. Cancer Inst. 77, 697-701 (1986)
3. Krontiris, T., Devlin, B , Karp, D., Robert, N & Risch, N. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus New Eng. J. Med. 329, 517-523 (1993).
4. Garret, P., Hulka, B , Kim, Y. & Farber, R HRAS protooncogene polymorphism and breast cancer. Cancer Epi Biomarkers Prevention 2, 131-138 (1993).
5. Narod, S. et al. Risk modifiers in carriers of BRCA1 mutations Int J. Cancer 64, 394-398 (1995)
6. Simard, J. et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families Nature Genet 8, 392-398 (1995)
7. Serova, O et al A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum. Genet. 58, 42-51 (1996)
8. Shattuck-Eidens, D et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene JAMA 273, 535-541 (1995).
9. Hogervorst, F et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet. 10, 208-212 (1995).
10. Castilla, L., et al Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet 8, 387-391 (1995)
11. Capon, D , Chen, E , Levinson, A., Seeburg, P & Goeddel, D Complete nucleotide sequence of the T24 human bladder carcinoma oncogene and it's normal homologue Nature 302, 33-37 (1983).
12. Cox, D. Regression models and life tables J. R Stat Soc. 1972 34, 187-220 (1972)
13. Trepicchio, W. & Krontiris, T. Members of the rel/NF-kB family of transcriptional regulatory factors bind the HRAS1 minisatellite DNA sequence Nucl. Acids Res 20, 2427-2434 (1892)
14. Green, M & Krontiris, T Allelic variation of reporter gene activation by the HRAS1 minisatellite Genomics 17, 429-434 (1993)
15. Spandidos, D & Holmes, L. Transcriptional enhancer activity in the variable tandem repeat DNA sequence downstream of the human Ha-ras-1 gene FEBS Lett 218, 41-46 (1987).
16. Ryberg, D Lindstedt, B , Zienolddiny, S & Haugen, A A herditary genetic marker closely associated with microsatellite instability in lung cancer. Cancer Res 55, 3996-3999 (1995)
17. Narod, S et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum. Genet 56, 254-264 (1995)
18. Decorte, R. Cuppens, H., Marynen, P. & Cassiman, J.-J. Rapid detection of hypervariable regions by the polymerase chain reaction technique DNA Cell Biol 9, 461-469 (1990).
19. Ardern, J et al Polymerase chain reaction analysis of allele frequency and loss at the Harvey Ras locus in myeloid malignancies Leukemia 7, 258-262 (1993)